Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Scholar Rock Holding Corporation(SRRK) | 6,897,652 | 6,897,652 | 0 | $379.37M | $333.29M | 31.69% | -$46.08M |
| Mineralys Therapeutics, Inc.(MLYS) | 5,871,018 | 5,871,018 | 0 | $158.40M | $147.54M | 14.03% | -$10.86M |
| Septerna, Inc.(SEPN) | 3,149,128 | 3,066,453 | -82,675 | $105.46M | $119.99M | 11.41% | +$14.53M |
| Alamar Biosciences Inc | 2,480,310 | 2,480,310 | 0 | $67.19M | $84.50M | 8.04% | +$17.31M |
| SpyGlass Pharma, Inc.(SGP) | 2,109,953 | 2,109,953 | 0 | $46.97M | $54.86M | 5.22% | +$7.89M |
| Alumis Inc | 6,345,219 | 7,235,809 | +890,590 | $178.55M | $53.47M | 5.08% | -$125.08M |
| Neurogene Inc.(NGNE) | 1,717,127 | 1,867,127 | +150,000 | $54.00M | $51.94M | 4.94% | -$2.06M |
| Kalaris Therapeutics, Inc.(KLRS) | 12,881,175 | 12,881,175 | 0 | $52.43M | $37.23M | 3.54% | -$15.20M |
| Inventiva S.A.ADS(IVA) | 6,314,805 | 6,314,805 | 0 | $23.87M | $23.30M | 2.22% | -$568.3K |
| Parabilis Medicines Inc | 556,044 | 556,044 | 0 | $15.22M | $17.95M | 1.71% | +$2.74M |
| Sutro Biopharma, Inc.(STRO) | 1,062,872 | 1,062,872 | 0 | $35.29M | $17.12M | 1.63% | -$18.16M |
| PMV Pharmaceuticals, Inc.(PMVP) | 0 | 7,240,000 | +7,240,000 | $0 | $12.09M | 1.15% | +$12.09M |
| Obsidian Therapeutics Inc | 0 | 837,173 | +837,173 | $0 | $11.49M | 1.09% | +$11.49M |
| Aquestive Therapeutics Inc | 2,500,000 | 2,434,367 | -65,633 | $10.40M | $11.27M | 1.07% | +$871.1K |
| vTv Therapeutics Inc.CL A(VTVT) | 298,496 | 354,730 | +56,234 | $11.24M | $10.94M | 1.04% | -$298.5K |
| Jade Biosciences Inc | 736,237 | 736,237 | 0 | $16.36M | $10.34M | 0.98% | -$6.02M |
| Nkarta, Inc.(NKTX) | 3,507,666 | 3,507,666 | 0 | $9.93M | $9.19M | 0.87% | -$736.6K |
| Rani Therapeutics Holdings, Inc.CL A(RANI) | 10,369,159 | 10,369,159 | 0 | $7.88M | $8.20M | 0.78% | +$317.3K |
| Artiva Biotherapeutics, Inc.(ARTV) | 954,861 | 954,861 | 0 | $9.26M | $6.80M | 0.65% | -$2.46M |
| AgomAb Therapeutics NVADS(AGMB) | 600,000 | 594,749 | -5,251 | $7.79M | $6.60M | 0.63% | -$1.19M |
| Eloxx Pharmaceuticals Inc | 400,000 | 400,000 | 0 | $5.55M | $6.12M | 0.58% | +$572.0K |
| ABIVAX Société AnonymeADS(ABVX) | 55,095 | 55,095 | 0 | $7.34M | $5.46M | 0.52% | -$1.89M |
| Coherus Oncology, Inc.(CHRS) | 3,428,571 | 3,383,565 | -45,006 | $4.80M | $4.09M | 0.39% | -$705.9K |
| X4 Pharmaceuticals, Inc.(XFOR) | 1,395,587 | 1,347,723 | -47,864 | $6.52M | $3.91M | 0.37% | -$2.61M |
| Upstream Bio, Inc.(UPB) | 353,717 | 300,361 | -53,356 | $2.45M | $1.58M | 0.15% | -$864.8K |
| Tcgx Acquisition CorpCL A | 0 | 100,000 | +100,000 | $0 | $1.25M | 0.12% | +$1.25M |
| Gossamer Bio Inc | 0 | 87,956 | +87,956 | $0 | $1.04M | 0.10% | +$1.04M |
| Gossamer Bio, Inc.(GOSS) | 7,222,559 | 0 | -7,222,559 | $1.19M | $0 | — | -$1.19M |